Sandra E. Rowland - 01 Mar 2023 Form 4 Insider Report for Xylem Inc. (XYL)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Mar 2023, 18:13:04 UTC
Prior SEC filing
28 Feb 2023
Next SEC filing
05 May 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Callie Plant, by power of attorney for Sandra E. Rowland

Key filing fact

Sandra E. Rowland filed Form 4 for Xylem Inc. (XYL) on 03 Mar 2023.

Key facts

  • This page summarizes Sandra E. Rowland's Form 4 filing for Xylem Inc. (XYL).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 03 Mar 2023, 18:13.

Change

  • Previous filing in this sequence was filed on 28 Feb 2023.
  • Current net transaction value: +$1,321,853.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XYL transaction

Common Stock

Tax liability

Transaction value
$156,588
Shares
-1,549
Change %
-9.3%
Price
$101.09
Shares after
15,110
Date
01 Mar 2023
Ownership
Direct
Footnotes
F1
XYL transaction

Common Stock

Award

Transaction value
$0
Shares
+4,204
Change %
+28%
Price
$0.000000
Shares after
19,314
Date
01 Mar 2023
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

XYL transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$1,478,441
Shares
+14,625
Change %
Price
$101.09
Shares after
14,625
Date
01 Mar 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
14,625
Exercise price
$101.09
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Reflects units withheld to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2021 (715) and March 1, 2022 (834) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).

Footnote F2

Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2024, March 1, 2025 and March 1, 2026.

Footnote F3

Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2024, March 1, 2025 and March 1, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .